Equity · Healthcare
GOSS
NASDAQGossamer Bio (GOSS)
The line runs 0.175 USD on 12 August through 10.60 USD on 9 November, on a scale from 0 to 15. Days the market did not trade hold the previous close, flat.
- Market cap
- 5.2B USD
- Revenue, year to Dec 2025
- 48.5M USD
- EPS, diluted, year to Dec 2025
- −0.75 USD
- 52-week range
- 0.1345 USD – 12 USD
- Avg volume
- 13.0K
- Mentions, 30 days
- 3
as of Nov 9, 2026
Have Gossamer Bio (GOSS) insiders bought or sold shares recently?
GOSS's newest Form 4 filing is dated 2 January 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Jan 2026 | Aranda RichardChief Medical Officer | Award | 93,750 | |
| 02 Jan 2026 | Christian WaageEVP, Tech Ops and Admin | Award | 84,500 | |
| 02 Jan 2026 | Giraudo BryanCOO/CFO | Award | 115,750 | |
| 02 Jan 2026 | Hasnain FaheemPresident & CEO | Award | 280,000 | |
| 02 Jan 2026 | Peterson CarynEVP, Regulatory Affairs | Award | 84,500 | |
| 02 Jan 2026 | Smith Robert Paul JRChief Commercial Officer | Award | 93,750 |
Which funds hold Gossamer Bio (GOSS)?
8 of the 45 institutional funds we track reported a Gossamer Bio position for the quarter ended 30 Jun 2026 — a combined 13.3M USD; the latest of those filings landed 14 Aug 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Added | 40,959,285 | 6.7M USD | +10,417.7% |
| AQR Capital Management | Added | 15,629,993 | 2.6M USD | +54.3% |
| Renaissance Technologies | Added | 11,629,896 | 1.9M USD | +854.9% |
| Two Sigma Investments | Added | 7,432,001 | 1.2M USD | +55.5% |
| Millennium Management | Added | 2,402,633 | 395K USD | +1,182.0% |
| Marshall Wace | New position | 2,114,988 | 338K USD | |
| Tudor Investment Corp | Added | 479,581 | 79K USD | +316.2% |
| Balyasny Asset Management | Trimmed | 104,232 | 17K USD | −98.2% |
What has been filed or recorded for Gossamer Bio (GOSS)?
The filings we hold for Gossamer Bio, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 12,724 shares | 124K USD notional · 0.003% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 20,066 shares | 186K USD notional · 0.004% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 6,204 shares | 61K USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 8,990 shares | 92K USD notional · 0.002% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 6,474 shares | 70K USD notional · 0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 19,691 shares | 210K USD notional · 0.004% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,410 shares | 26K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 94 shares | 1K USD notional · <0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 133 shares | 1K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.08 USD | Revenue $9M |
| 30 Jun 2026 | Financials | Total assets | 76.9M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −94.0M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.20 USD | Revenue $17M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.75 USD | Revenue $48M |
| 31 Dec 2025 | Financials | Revenue | 48.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −170.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.75 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.21 USD | Revenue $13M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.17 USD | Revenue $11M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.16 USD | Revenue $10M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.25 USD | Revenue $115M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.14 USD | Revenue $9M |
What is Reddit saying about Gossamer Bio (GOSS)?
Reddit mentioned GOSS 3 times in the 30 days to 10 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 67% read bullish, 0% bearish and 33% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Gossamer Bio (GOSS) compare with its price?
Share ↗
Which subreddits are talking about Gossamer Bio (GOSS)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/asx | 33% | 1 | −0.03 |
| r/asx_bets | 33% | 1 | +0.12 |
| r/ausfinance | 33% | 1 | +0.55 |
What do people ask about Gossamer Bio (GOSS)?
What did Gossamer Bio shares close at?10.60
Gossamer Bio closed at 10.60 USD on 9 Nov 2026, up 8.72% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Gossamer Bio’s market cap?5.2B
Gossamer Bio is worth 5.2B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Gossamer Bio’s revenue?48.5M
Gossamer Bio reported revenue of 48.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Gossamer Bio insiders bought or sold shares recently?
No Gossamer Bio insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 2 Jan 2026 (SEC Form 4). See Insiders
Which funds own Gossamer Bio?8 of 45
8 of the 45 funds we track reported a Gossamer Bio position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., AQR Capital Management and Renaissance Technologies. See Funds
When did Gossamer Bio last report earnings?−0.08
Gossamer Bio last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.08 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Gossamer Bio?0 mentions
Gossamer Bio was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of the 3 mentions scored for sentiment, 67% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings